Authors: Chemtob, D Epstein, L Slater, PE Weiler-Ravell, D

Citation: D. Chemtob et al., Epidemiological analysis of tuberculosis treatment outcome as a tool for changing TB control policy in Israel, ISR MED ASS, 3(7), 2001, pp. 479-483

Authors: Grossman, Z Vardinon, N Chemtob, D Alkan, ML Bentwich, Z Burke, M Gottesman, G Istomin, V Levi, I Maayan, S Shahar, E Schapiro, JM

Citation: Z. Grossman et al., Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B (vol 15, pg 1453, 2001), AIDS, 15(16), 2001, pp. 2209-2209

Authors: Grossman, Z Vardinon, N Chemtob, D Alkan, ML Bentwich, Z Burke, M Gottesman, G Istomin, V Levi, I Maayan, S Shahar, E Schapiro, JM

Citation: Z. Grossman et al., Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B, AIDS, 15(12), 2001, pp. 1453-1460

Authors: Ravins, M Bercovier, H Chemtob, D Fishman, Y Rahav, G

Citation: M. Ravins et al., Molecular epidemiology of Mycobacterium tuberculosis infection in Israel, J CLIN MICR, 39(3), 2001, pp. 1175-1177

Authors: Chemtob, D Weiler-Ravell, D

Citation: D. Chemtob et D. Weiler-ravell, Incorrect estimation of TB drug resistance in Israel, probably due to recruitment and collection biases, INT J TUBE, 4(10), 2000, pp. 990-991

Authors: Srour-Fihmi, S Weiler-Ravell, D Kitzes, R Chemtob, D

Citation: S. Srour-fihmi et al., Routine two-step skin testing for tuberculosis in the staff of a geriatrichospital in Israel: booster and conversion rates, J HOSP INF, 46(2), 2000, pp. 141-146